Day: September 3, 2026

Rhelion Life Sciences Confirms Further Delivery of Filament Health’s PEX010 to Germany’s First Psilocybin Compassionate Use Program

Filament Health has completed a further international delivery of its patented, naturally derived psilocybin drug candidate PEX010 to Germany, supporting...

error: Content is protected !!